North America Organoids Market Projected to Reach US$ 5.35 Billion by 2030, Riding on a CAGR of 21.5%

Dublin, Feb. 16, 2024 (GLOBE NEWSWIRE) -- The "North America Organoids Market Forecast to 2030 - Regional Analysis - by Organ Type, Application, Source, and Type" report has been added to's offering.

The North America organoids market is poised for a substantial growth forecasted from US$ 1.125 billion in 2022 to a staggering US$ 5.35 billion by 2030. This sharp incline, estimated at a CAGR of 21.5% during the forecast period, can be attributed to several factors, including the increasing adoption of personalized medicine and advancements in stem cell research.

This comprehensive analysis of the market offers in-depth insights into the organ type, application, source, and various types encapsulating the North America organoids market.

Advancements in Personalized Medicine Propelling Organoid Market Growth

One significant driver behind the vigorous North America organoids market growth is the rising inclination towards personalized or precision medicine. This cutting-edge medical model enhances drug development and treatment strategies, tailored to individual patient profiles based on genetic information and disease susceptibility. The role of organoids in revolutionizing personalized drug therapies plays a fundamental part in this sector's expansion, creating a robust platform for patient-specific treatment protocols.

Key Market Segment Highlights

The extensive report illuminates the diverse segments within the organoid market:

  • Organ Type: The intestine segment currently leads the market, owing to its comprehensive applications in the study of various diseases and disorders.
  • Application: Developmental biology disease research was the dominant application area in recent years, reflecting a clear demand for understanding developmental pathologies.
  • Source: Pluripotent stem cells emerged as the larger source segment of organoids, underscoring the versatility and transformative potential of these cells in organoid technology.
  • Type: Consumables held a strikingly large market share, indicating the recurrent need for these products in organoid research and applications.

A thoughtful analysis of these segments provides valuable insights into the marketplace, guiding stakeholder decisions and spotlighting growth opportunities.

Regional Analysis: The United States Takes the Lead

The US continues to dominate the North American market, powered by a significant increase in the number of patients with chronic and infectious diseases, vital R&D activities, and the solid commercialization of organoid models. Enhanced funding and grants for organoid development contribute markedly to the thriving market in the region.

The research publication accentuates the efforts of key industry players, including innovators and technology leaders that contribute to the organoids market landscape. These stakeholders drive forward the organoids sector, ensuring its steady growth and facilitating advancements in personalized medicine, drug discovery, and regenerative therapies.

With a comprehensive analysis of the current trends, drivers, and barriers, the latest research publication on the North America organoids market offers an indispensable resource for understanding the market's trajectory and preparing for the upcoming developments that are set to redefine the organoids landscape by 2030.

Key Attributes:

Report AttributeDetails
No. of Pages90
Forecast Period2022 - 2030
Estimated Market Value in 20221.13 Billion
Forecasted Market Value by 20305.36 Billion
Compound Annual Growth Rate21.5%
Regions CoveredNorth America

Key Topics Covered:

1. Introduction

2. Executive Summary
2.1 North America Key Insights
2.2 North America Market Attractiveness

3. Research Methodology

4. North America Organoids Market Landscape
4.1 Overview
4.2 North America PEST Analysis

5. North America Organoids Market - Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Increasing Demand for Tumor Modeling and Biobanking
5.1.2 Growing Adoption of Personalized Drugs
5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
5.2 Key Market Restraints:
5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
5.2.2 Dearth of Skilled Professionals
5.3 Key Market Opportunities:
5.3.1 Focus on Drug Discovery Activities
5.4 Future Trends:
5.4.1 Combining Organoid with Organ-On-A-Chip
5.5 Impact Analysis:

6. Organoids Market - North America Market Analysis
6.1 North America Organoids Market Revenue (US$ Mn), 2022 - 2030

7. North America Organoids Market - Revenue and Forecast to 2030 - by Organ Type
7.1 Overview
7.2 North America Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
7.3 Stomach
7.4 Intestine
7.5 Liver
7.6 Pancreas
7.7 Lung
7.8 Brain
7.9 Kidney

8. North America Organoids Market - Revenue and Forecast to 2030 - by Application
8.1 Overview
8.2 North America Organoids Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Developmental Biology
8.4 Disease Pathology of Infectious Disease
8.5 Regenerative Medicine
8.6 Drug Toxicity and Efficacy Testing
8.7 Drug Discovery and Personalized Medicine

9. North America Organoids Market - Revenue and Forecast to 2030 - by Source
9.1 Overview
9.2 North America Organoids Market Revenue Share, by Source 2022 & 2030 (%)
9.3 Pluripotent Stem Cells
9.4 Organ-specific Adult Stem Cells

10. North America Organoids Market - Revenue and Forecast to 2030 - by Type
10.1 Overview
10.2 North America Organoids Market Revenue Share, by Type 2022 & 2030 (%)
10.3 Instruments
10.4 Consumables
10.5 Services

11. North America Organoids Market - Country Analysis
11.1 North America: Overview
11.1.1 North America Organoids Market, by Country

12. Pre & Post COVID-19 Impact
12.1 Pre & Post Covid-19 Impact

13. North America Organoids Market Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.4 Inorganic Developments

14. North America Organoids Market, Key Company Profiles

  • STEMCELL Technologies Inc
  • Cellesce
  • Organoid Therapeutics
  • 3Dnamics Inc
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • InSphero

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


North American Organoids Market

Contact Data